Lopinavir CAS 192725-17-0 API Mai hana cutar HIV Mai hana COVID-19 Babban Tsabta
Samar da Mai ƙira tare da Tsaftataccen Tsafta da Tsayayyen inganci
Sunan Chemical: Lopinavir
Saukewa: 192725-17-0
Mai Ƙarfi Mai Ƙarfi, Zaɓaɓɓen Peptidomimetic HIV-1 Protease Inhibitor
Samfurin Bincike mai alaƙa da COVID-19
API High Quality, Kasuwancin Kasuwanci
Sunan Sinadari | Lopinavir |
Makamantu | LPV;ABT-378;Kaletra |
Lambar CAS | 192725-17-0 |
Lambar CAT | RF-API73 |
Matsayin Hannun jari | A Hannun jari, Ma'aunin Samfuran Har zuwa Daruruwan Kilogram |
Tsarin kwayoyin halitta | Saukewa: C37H48N4O5 |
Nauyin Kwayoyin Halitta | 628.81 |
Adana Tsawon Lokaci | Ajiye Dogon lokaci a 2-8 ℃ |
Alamar | Ruifu Chemical |
Abu | Ƙayyadaddun bayanai |
Bayyanar | Fari zuwa Kashe-Farin Foda |
Solubility | Soluble a cikin Methanol kuma a cikin Ethanol, Mai Soluble a cikin 2-Propanol |
Gano IR | Bakan shayarwar infrared na samfurin gwajin ya yi daidai da bakan ma'aunin tunani |
Bayanin HPLC | Lokacin riƙewar samfurin gwajin yayi daidai da na ƙa'idar tunani |
Abubuwan Ruwa (na KF) | ≤4.0% |
Takamaiman Juyawar gani | -22.0° zuwa -26.0° |
Ragowa akan Ignition | ≤0.20% |
Karfe masu nauyi | ≤20ppm |
Matsayin narkewa | 124.0 zuwa 127.0 ℃ |
Sulfate ash | ≤0.20% |
Residual Solvent (Ethanol) | ≤0.50% |
Abubuwa masu alaƙa | (HPLC, Yanki%) |
Rashin tsarki 1 | |
Najasa B (RRT=0.07) | ≤0.20% |
Najasa I (RRT=1.10) | ≤0.20% |
Duk Wani Najasa | ≤0.10% |
Rashin tsarki 2 | Duk Wani Rashin Tsabtace Mutum ≤0.10% |
Jimlar ƙazanta daga tsari na 1 da 2 | ≤0.70% |
Jimlar ƙazanta | ≤1.0% |
Assay (ta HPLC) | 98.0% ~ 102.0% |
Matsayin Gwaji | Matsayin Kasuwanci |
Amfani | Zaɓaɓɓen Peptidomimetic HIV-1 Mai hana Protease, Samfurin Bincike mai alaƙa da COVID-19 |
Kunshin: Bottle, Aluminum tsare jakar, Kwali drum, 25kg / Drum, ko bisa ga abokin ciniki ta bukata.
Yanayin Ajiya:Ajiye a cikin kwantena da aka rufe a wuri mai sanyi da bushe;Kare daga haske, danshi da kamuwa da kwari.
Lopinavir (ABT-378) mai ƙarfi ne mai ƙarfi, mai zaɓin peptidomimetic inhibitor na kwayar cutar HIV-1, tare da Kis na 1.3 zuwa 3.6 pM don nau'in daji da ƙwayoyin cuta na mutant HIV.Lopinavir yana aiki ta hanyar kama balaga na HIV-1 don haka yana toshe kamuwa da cuta.Lopinavir kuma shine mai hana SARS-CoV 3CLpro tare da IC50 na 14.2 μM.Lopinavir maganin rigakafi ne na aji mai hana protease.Hana kwayar cutar HIV-1 yana hana ɓarkewar ƙwayar cuta ta polyprotein precursor kuma yana haifar da sakin marasa balagagge, virions marasa kamuwa da cuta.Wani bangare na maganin hadewa don magance cutar kanjamau.Lopinavir, mai hana cutar HIV na shida a cikin aji na "navir", an ƙaddamar da shi a cikin haɗin gwiwa tare da ritonavir, wani mai hana cutar HIV wanda aka riga aka sayar (Abbott, 1996);An gabatar da wannan tsari na asali a matsayin Kaletra don amfani da shi tare da ko dai nucleoside ko wadanda ba na nucleoside masu hana masu hanawa ba don maganin AIDS a cikin manya da yara.Lopinavir wani fili ne na peptidomimetic tare da tushen tsarin daidai da na ritonavir, wanda aka gabatar da ƙungiyoyin tasha, musamman valine da aka gyara, ta hanyoyin haɗin peptide.Lopinavir babban mai hana cutar HIV-I protease ne wanda ke nuna babban yuwuwar rigakafin maye gurbi na ritonavir.A cikin nau'ikan dabbobi da yawa, nazarin pharmacokinetic tare da ƙungiyar lopinavirlritonavir sun nuna cewa ƙayyadaddun kaddarorin lopinavir sun inganta sosai a gaban ritonavir, dangane da Cmax da tsawon lokacin aiki.